Sign up to save your podcasts
Or
Share Recently Approved Drugs: Pembrolizumab for cHL
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Recently Approved Drugs: Pembrolizumab for cHL
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
View all episodes
By American Society of Clinical Oncology (ASCO)
4.5
3131 ratings
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
More shows like ASCO Education
View all
NEJM This Week
317 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
JCO Oncology Practice Podcast
17 Listeners
ASCO Daily News
58 Listeners
The Curbsiders Internal Medicine Podcast
3,337 Listeners
ASCO Guidelines
45 Listeners
The Readout Loud
321 Listeners
OncLive® On Air
22 Listeners
Money Meets Medicine
227 Listeners
Oncology Today with Dr Neil Love
57 Listeners
The Foreign Affairs Interview
453 Listeners
Not Otherwise Specified
64 Listeners
Two Onc Docs
192 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
44 Listeners
The Best People with Nicolle Wallace
4,454 Listeners